Issue Spotlight:
Immuno-oncology: tools of tomorrow 2023
Issue Spotlight:
Leveraging the cutting-edge TME toolkit
Issue Spotlight:
How to move towards precision I-O? Innovation in biomarker R&D
Issue Spotlight:
Safety: what progress in understanding and addressing immune-related adverse events?
Issue Spotlight:
Combination therapy development: strategic directions towards improving current I-O response rates
Issue Spotlight:
Optimizing clinical development strategy for the rapidly evolving I-O field
Issue Spotlight:
Dissecting investor and market access trends and drivers for I-O R&D insights
Issue Spotlight:
Anticipating immuno-oncology modality/platform development trends for 2022